Valuation: Lead Data Inc.

Market Cap 539M 16.53M 14.76M 13.63M 12.36M 23.12M 1.57B 23.5M 164M 64.96M 822M 62.03M 60.71M 2.59B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.42M 15.56M 14.37M 13.02M 24.37M 1.65B 24.77M 173M 68.47M 866M 65.38M 63.99M 2.73B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 17/08/2022
Director of Finance/CFO - 10/06/2022
Corporate Officer/Principal - 10/06/2022
Director TitleAgeSince
Director/Board Member - 10/06/2019
Chairman - 17/08/2022
Director/Board Member - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+31.73% 16.53M
+1.16%-1.13%-18.25%+9.38% 179B
+0.02%+4.24%-19.55%+15.88% 118B
-1.22%+0.70%+1.86%+32.59% 117B
+2.29%+17.36%-42.18%+8.22% 93.26B
-2.21%-2.91%-0.51%+75.12% 63.16B
-1.06%+1.75%+13.48%+74.12% 55.68B
-0.75%+3.73%+7.04%-23.26% 54.18B
-1.13%+0.00%-12.56%+30.09% 44.15B
+0.17%+5.85%-5.20%-11.43% 33.95B
Average -1.26%+1.09%-7.59%+24.24% 75.84B
Weighted average by Cap. -0.00%+3.09%-11.77%+21.99%

Financials

2024 2025
Net sales 15.47M 474K 424K 391K 355K 664K 45.04M 675K 4.71M 1.86M 23.6M 1.78M 1.74M 74.4M 111M 3.4M 3.03M 2.8M 2.54M 4.75M 322M 4.83M 33.71M 13.35M 169M 12.74M 12.47M 532M
Net income -134M -4.1M -3.67M -3.39M -3.07M -5.74M -390M -5.84M -40.75M -16.13M -204M -15.4M -15.08M -644M -44.02M -1.35M -1.21M -1.11M -1.01M -1.89M -128M -1.92M -13.41M -5.31M -67.17M -5.07M -4.96M -212M
Net Debt -16.95M -520K -464K -429K -389K -727K -49.37M -739K -5.16M -2.04M -25.87M -1.95M -1.91M -81.55M 29.12M 893K 798K 737K 668K 1.25M 84.8M 1.27M 8.87M 3.51M 44.43M 3.35M 3.28M 140M
Projected Income Statement - Annual - Lead Data Inc.
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock